Home / Featured Companies / Amgen Historical Data

Amgen (AMGN) Financials

Amgen (AMGN) Historical Financial Statements and Key Metrics for 1986 - 2025

Full Amgen financials for 1986 - 2025 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Amgen Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2025-Mar-31 8,149 5,181 (63.6 %) 1,178 (14.5 %) 1,730 (21.2 %) 1,178 3.20
2024-Dec-31 9,086 5,974 (65.7 %) 2,311 (25.4 %) 627 (6.9 %) 2,926 1.16
2024-Sep-30 8,503 5,193 (61.1 %) 2,047 (24.1 %) 2,830 (33.3 %) 5,288 5.22
2024-Jun-30 8,333 5,097 (61.2 %) 1,854 (22.2 %) 746 (9.0 %) 3,254 1.38
2024-Mar-31 7,396 4,196 (56.7 %) 940 (12.7 %) -113 (-1.5 %) 2,339 -0.21
2023-Dec-31 8,196 5,084 (62.0 %) 1,271 (15.5 %) 767 (9.4 %) 3,053 1.42
2023-Sep-30 6,903 5,097 (73.8 %) 2,021 (29.3 %) 1,730 (25.1 %) 2,706 3.22
Full historical income statements for 1986 - 2025 is included in the US Historical Financials dataset.

Amgen Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2025-Mar-31 89,367 83,160 57,381 6,207 8,810
2024-Dec-31 91,839 85,962 60,099 5,877 11,973
2024-Sep-30 90,883 83,356 60,398 7,527 9,011
2024-Jun-30 90,907 84,982 62,645 5,925 9,301
2024-Mar-31 92,980 87,958 64,020 5,022 9,708
2023-Dec-31 97,154 90,922 64,613 6,232 10,944
2023-Sep-30 90,534 82,878 60,468 7,656 34,741
Full historical balance sheet data for 1986 - 2025 is included in the US Historical Financials dataset.

Amgen Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2025-Mar-31 1,391 -447 -4,107 980
2024-Dec-31 4,771 -402 -1,407 4,400
2024-Sep-30 3,571 -210 -3,651 3,314
2024-Jun-30 2,459 -217 -2,649 2,221
2024-Mar-31 689 -217 -1,708 459
2023-Dec-31 538 -27,089 2,754 289
2023-Sep-30 2,760 -262 -2,005 2,760
Full historical cash flow data for 1986 - 2025 is included in the US Historical Financials dataset.

Amgen Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2025-Mar-31 167,614 216,185 20.57 24.22 27.00
2024-Dec-31 140,880 189,006 15.51 56.17 23.97
2024-Sep-30 173,027 224,414 20.35 15.29 22.99
2024-Jun-30 167,012 220,356 20.04 55.97 28.19
2024-Mar-31 151,709 206,021 20.51 -335.64 30.21
2023-Dec-31 154,091 207,760 18.80 50.23 24.73
2023-Sep-30 143,787 169,514 20.83 20.78 18.78
Full historical valuation and operating metrics for 1986 - 2025 are included in the US Historical Financials dataset.